A new Australian-developed blood test could help 30 million American diabetics predict whether they will develop kidney disease.
Using technology developed by a Perth-based firm, doctors in the United States will be able to predict whether diabetes patients will require a kidney transplant or dialysis within four years, giving them a chance to avert a health crisis.
Current tests can only detect diabetic kidney disease once there has been damage done to the organ as there are no early symptoms.
The Australian test kit, called PromarkerD, was developed by Proteomics International to run proteins found in the blood which act as biomarker “fingerprints” through an algorithm that determines the likelihood of a diabetic’s kidney deteriorating.
